Titre:
  • A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.
Auteur:Pachl, Jan; Svoboda, Petr; Jacobs, Frédérique; Vandewoude, K; van der Hoven, Ben; Spronk, Peter; Masterson, Gary; Malbrain, Manu; Aoun, Michel; Garbino, Jorge; Takala, Jukka; Drgona, L.; Burnie, James; Matthews, Ruth; Mycograb Invasive Candidiasis Study Group,
Informations sur la publication:Clinical infectious diseases, 42, 10, page (1404-1413)
Statut de publication:Publié, 2006-05
Sujet CREF:Cancérologie
MeSH keywords:Adult
Aged
Amphotericin B -- therapeutic use
Antibodies, Monoclonal -- therapeutic use
Antifungal Agents -- therapeutic use
Candida -- classification -- isolation & purification
Candidiasis -- drug therapy -- physiopathology
Double-Blind Method
Female
HSP90 Heat-Shock Proteins -- antagonists & inhibitors
Humans
Male
Middle Aged
Patient Selection
Placebos
Recombinant Proteins -- therapeutic use
Treatment Outcome
Note générale:Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1058-4838
info:doi/10.1086/503428
info:pii/CID38863
info:scp/33646455866
info:pmid/16619152